Skip to main content
. 2017 Mar 21;17:206. doi: 10.1186/s12885-017-3191-y

Table 1.

Clinicopathological characteristics of patients with primary invasive breast cancer and ovarian metastases

Clinicopathological characteristics N = 46 %
Age at diagnosis of breast cancer, years - median (range) 36.5 (28–40) -
BRCA gene mutation
 No 8 17.4
 Yes, BRCA 1 1 2.2
 Yes, BRCA 2 0 0.0
 Unknown 37 80.4
Breast tumor localization
 Left 23 50.0
 Right 21 45.7
 Both 2 4.3
Most extensively performed breast surgery
 Needle biopsy 4 8.7
 Breast conserving surgery 15 32.6
 Mastectomy 27 58.7
Breast tumor histological subtype
 Ductal 36 78.2
 Lobular 5 10.9
 Ductolobular 5 10.9
Scarff-Bloom-Richardson grade
 I 4 8.7
 II 19 41.3
 III 15 32.6
 Unknown 8 17.4
Estrogen receptor
 Negative 5 10.9
 Positive 41 89.1
Progesterone receptor
 Negative 8 17.4
 Positive 38 82.6
Her2/neu receptor
 Negative 38 82.6
 Positive 8 17.4
Tumor stage
 T1 11 23.9
 T2 24 52.2
 T3 7 15.2
 T4 4 8.7
Nodal stage
 N0 14 30.4
 N1 12 26.1
 N2 10 21.7
 N3 10 21.7
Distant metastasis
 cM0 39 84.8
 cM1 7 15.2
Age at diagnosis of ovarian metastases, years - median (range) 40.0 (31–51) -
Time between breast cancer and ovarian metastases, months - median (range) 41.9 (0.3–141.8) -
Recurrent disease prior to oophorectomy
 No 15 32.6
 Yes, locoregional recurrence 12 26.1
 Yes, distant recurrence 19 41.3
Type of ovarian surgery
 Unilateral oophorectomy 0 0.0
 Bilateral oophorectomy 46 100.0
Indication for oophorectomy
 Prophylactic because of breast cancer 9 19.6
 Therapeutic because of breast cancer 25 54.3
 Abnormal ovaries on ultrasound 12 26.1
Localization of ovarian metastases
 Left 4 8.7
 Right 6 13.0
 Both 29 63.0
 Unknown 7 15.2